ConductScience.org, home

Trial · NCT02476916

Results by group86

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
Percentage of Participants Experiencing at Least One Adverse Event (AEs) in the Core PeriodAG-348 50 mg BID96.3percentage of participants
Percentage of Participants Experiencing at Least One Adverse Event (AEs) in the Core PeriodAG-348 300 mg BID100.0percentage of participants
Change From Baseline in Hemoglobin (Hb) Value at Week 24AG-348 50 mg BIDBaseline9.243Standard Deviation 1.4757grams per deciliter (g/dL)
Change From Baseline in Hemoglobin (Hb) Value at Week 24AG-348 300 mg BIDBaseline8.636Standard Deviation 1.1664grams per deciliter (g/dL)
Change From Baseline in Hemoglobin (Hb) Value at Week 24AG-348 50 mg BIDChange at Week 241.205Standard Deviation 1.4181grams per deciliter (g/dL)
Change From Baseline in Hemoglobin (Hb) Value at Week 24AG-348 300 mg BIDChange at Week 241.611Standard Deviation 1.7058grams per deciliter (g/dL)
Change From Baseline in Hematocrit at Week 24AG-348 50 mg BIDBaseline0.289Standard Deviation 0.0470volume per volume (V/V)
Change From Baseline in Hematocrit at Week 24AG-348 300 mg BIDBaseline0.268Standard Deviation 0.0367volume per volume (V/V)
Change From Baseline in Hematocrit at Week 24AG-348 50 mg BIDChange at Week 240.033Standard Deviation 0.0414volume per volume (V/V)
Change From Baseline in Hematocrit at Week 24AG-348 300 mg BIDChange at Week 240.045Standard Deviation 0.0499volume per volume (V/V)
Change From Baseline in Reticulocyte Count at Week 24AG-348 50 mg BIDBaseline493.248Standard Deviation 234.2242cells * 10^9/liter
Change From Baseline in Reticulocyte Count at Week 24AG-348 300 mg BIDBaseline549.436Standard Deviation 291.5301cells * 10^9/liter
Change From Baseline in Reticulocyte Count at Week 24AG-348 50 mg BIDChange at Week 24-99.248Standard Deviation 309.9473cells * 10^9/liter
Change From Baseline in Reticulocyte Count at Week 24AG-348 300 mg BIDChange at Week 24-46.222Standard Deviation 351.9823cells * 10^9/liter
Change From Baseline in Haptoglobin at Week 24AG-348 50 mg BIDBaseline0.246Standard Deviation 0.1474gram per liter (g/L)
Change From Baseline in Haptoglobin at Week 24AG-348 300 mg BIDBaseline0.240Standard Deviation 0.2082gram per liter (g/L)
Change From Baseline in Haptoglobin at Week 24AG-348 50 mg BIDChange at Week 240.128Standard Deviation 0.2845gram per liter (g/L)
Change From Baseline in Haptoglobin at Week 24AG-348 300 mg BIDChange at Week 240.139Standard Deviation 0.2726gram per liter (g/L)
Change From Baseline in Carbon Monoxide at Week 24AG-348 50 mg BIDBaseline5.263Standard Deviation 1.7270percentage Hb bound to carbon monoxide
Change From Baseline in Carbon Monoxide at Week 24AG-348 300 mg BIDBaseline6.200Standard Deviation 2.3079percentage Hb bound to carbon monoxide

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02476916/results